Clinical Trial Update: An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Ga-68 PSMA-11 PET/CT as a diagnostic scan to detect therapy response in metastatic adenoid cystic carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• Ga-68 PSMA-11 PET/CT tracer (Gallium-68 labeled PSMA-11)

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Adenoid Cystic Carcinoma | Phase 2 | Status: COMPLETED